84 related articles for article (PubMed ID: 4836677)
21. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
[TBL] [Abstract][Full Text] [Related]
22. Palliative treatment of metastasized breast cancer with 5-FU in slow intravenous infusion.
Huys J; Van Vaerenbergh PM
Rev Fr Etud Clin Biol; 1969 Oct; 14(8):775-80. PubMed ID: 4189483
[No Abstract] [Full Text] [Related]
23. [Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy].
Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1029-32. PubMed ID: 8210253
[TBL] [Abstract][Full Text] [Related]
24. Allopurinol modulation of high-dose fluorouracil toxicity.
Fox RM; Woods RL; Tattersall HN; Brodie GW
Cancer Treat Rev; 1979 Jun; 6 Suppl():143-7. PubMed ID: 498168
[No Abstract] [Full Text] [Related]
25. [Two patients with far advanced gastric cancer responding to combination chemotherapy with 5-FU and CDDP].
Mochizuki F; Tomioka K; Mizuno Y; Sato F; Yamagata T; Nagakawa Y; Kobari Y; Fujii M; Iwai S; Tanaka T
Gan To Kagaku Ryoho; 1995 Jan; 22(1):115-8. PubMed ID: 7826065
[TBL] [Abstract][Full Text] [Related]
26. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
Gu Y; Shu Y; Xu Q
Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
[TBL] [Abstract][Full Text] [Related]
27. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
28. A pilot trial of combination cisplatin, 5-fluorouracil and interferon-alpha in the treatment of advanced esophageal carcinoma.
Bazarbashi S; Rahal M; Raja MA; El Weshi A; Pai C; Ezzat A; Ajarim D; Memon M; Al Fadda M
Chemotherapy; 2002 Sep; 48(4):211-6. PubMed ID: 12218269
[TBL] [Abstract][Full Text] [Related]
29. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
[No Abstract] [Full Text] [Related]
30. Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer.
Lokich JJ; Pitman SW; Skarin AT
Oncology; 1975; 32(1):34-7. PubMed ID: 1208028
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
[TBL] [Abstract][Full Text] [Related]
32. A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
Kovach JS; Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
Oncology; 1974; 29(1):34-9. PubMed ID: 4837137
[No Abstract] [Full Text] [Related]
33. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.
Stolinsky DC; Pugh RP; Bateman JR
Cancer Chemother Rep; 1975; 59(5):1031-3. PubMed ID: 1106846
[No Abstract] [Full Text] [Related]
34. Failure of allopurinol to provide clinically significant protection against the hematologic toxicity of a bolus 5-FU schedule.
Garewal H; Ahmann FR
Oncology; 1986; 43(4):216-8. PubMed ID: 3725283
[TBL] [Abstract][Full Text] [Related]
35. [Toxicities associated with chemotherapy in colorectal cancer].
Ura T; Shirao K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():374-8. PubMed ID: 14574916
[No Abstract] [Full Text] [Related]
36. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer.
Okabe S; Ishikawa T; Tanami H; Kuwabara H; Fukahara T; Udagawa M; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817
[TBL] [Abstract][Full Text] [Related]
37. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
38. TREATMENT OF ADVANCED CANCER WITH 5-FLUOROURACIL.
HURLEY JD
Acta Unio Int Contra Cancrum; 1964; 20():363-5. PubMed ID: 14151930
[No Abstract] [Full Text] [Related]
39. FLUORINATED PYRIMIDINE THERAPY OF ADVANCED GASTROINTESTINAL CANCER.
MOERTEL CG; REITEMEIER RJ; HAHN RG
Gastroenterology; 1964 Apr; 46():371-8. PubMed ID: 14144605
[No Abstract] [Full Text] [Related]
40. Corticosteroids and fluorouracil toxicity.
Horton J; Olson KB; Hosley HF
Arch Intern Med; 1966 Jun; 117(6):775-7. PubMed ID: 5327216
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
